257 related articles for article (PubMed ID: 37696088)
1. N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
Wang D; Zhang Y; Li Q; Zhang A; Xu J; Li Y; Li W; Tang L; Yang F; Meng J
Biomed Pharmacother; 2023 Nov; 167():115477. PubMed ID: 37696088
[TBL] [Abstract][Full Text] [Related]
2. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
Lin H; Wang Y; Wang P; Long F; Wang T
Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
[TBL] [Abstract][Full Text] [Related]
3. Regulatory effects of natural products on N6-methyladenosine modification: A novel therapeutic strategy for cancer.
Mao-Mao ; Zhang JJ; Xu YP; Shao MM; Wang MC
Drug Discov Today; 2024 Feb; 29(2):103875. PubMed ID: 38176674
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine (m6A) in cancer stem cell: From molecular mechanisms to therapeutic implications.
Wang L; Tang Y
Biomed Pharmacother; 2023 Jul; 163():114846. PubMed ID: 37167725
[TBL] [Abstract][Full Text] [Related]
5. The Role of m6A-Mediated DNA Damage Repair in Tumor Development and Chemoradiotherapy Resistance.
Qu L; Liu SJ; Zhang L; Liu JF; Zhou YJ; Zeng PH; Jing QC; Yin WJ
Cancer Control; 2024; 31():10732748241247170. PubMed ID: 38662732
[TBL] [Abstract][Full Text] [Related]
6. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
Chen M; Wong CM
Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of RNA modification N6-methyladenosine in human cancer.
Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine functions and its role in skin cancer.
Ran Y; Yan Z; Jiang B; Liang P
Exp Dermatol; 2023 Jan; 32(1):4-12. PubMed ID: 36314059
[TBL] [Abstract][Full Text] [Related]
9. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Qin S; Mao Y; Wang H; Duan Y; Zhao L
Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
[TBL] [Abstract][Full Text] [Related]
10. m6A modification: recent advances, anticancer targeted drug discovery and beyond.
Deng LJ; Deng WQ; Fan SR; Chen MF; Qi M; Lyu WY; Qi Q; Tiwari AK; Chen JX; Zhang DM; Chen ZS
Mol Cancer; 2022 Feb; 21(1):52. PubMed ID: 35164788
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
[TBL] [Abstract][Full Text] [Related]
12. Functions of N6-methyladenosine and its role in cancer.
He L; Li H; Wu A; Peng Y; Shu G; Yin G
Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
[TBL] [Abstract][Full Text] [Related]
13. The interplay between m6A RNA methylation and noncoding RNA in cancer.
Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.
Xu Z; Peng B; Cai Y; Wu G; Huang J; Gao M; Guo G; Zeng S; Gong Z; Yan Y
Biochem Pharmacol; 2020 Dec; 182():114258. PubMed ID: 33017575
[TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
[TBL] [Abstract][Full Text] [Related]
16. Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
Liu WW; Wang H; Zhu XY
Biomark Res; 2022 Aug; 10(1):64. PubMed ID: 35999621
[TBL] [Abstract][Full Text] [Related]
17. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
18. The role of m6A methylation in therapy resistance in cancer.
Zhuang H; Yu B; Tao D; Xu X; Xu Y; Wang J; Jiao Y; Wang L
Mol Cancer; 2023 Jun; 22(1):91. PubMed ID: 37264402
[TBL] [Abstract][Full Text] [Related]
19. Surmounting cancer drug resistance: New insights from the perspective of N
Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
[TBL] [Abstract][Full Text] [Related]
20. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
